[an error occurred while processing this directive] | [an error occurred while processing this directive]
Current status and advances in clinical diagnosis and treatment of mucosal melanoma of the head and neck
Sun Shiran, Yi Junlin
Department of Radiation Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100021,China
Abstract Mucosal melanoma of the head and neck (MMHN) is a rare malignancy. The sinonasal cavity and oral cavity are the most common primary sites. MMHN is a very aggressive malignant tumor, with the 5-year overall survival (OS) rate less than 30%. Currently, the optimal treatment modality remains unclear. In the majority of available retrospective studies, postoperative radiotherapy improves the local control of MMHN, but without significant effect on OS. This article aims to improve our understanding of the clinical features, diagnosis, staging, treatment modalities, and outcomes of this malignancy.
Corresponding Authors:
Yi Junlin,Email:yijunlin1969@163.com
Cite this article:
Sun Shiran,Yi Junlin. Current status and advances in clinical diagnosis and treatment of mucosal melanoma of the head and neck[J]. Chinese Journal of Radiation Oncology, 2017, 26(4): 466-469.
Sun Shiran,Yi Junlin. Current status and advances in clinical diagnosis and treatment of mucosal melanoma of the head and neck[J]. Chinese Journal of Radiation Oncology, 2017, 26(4): 466-469.
[1] Chang AE,Karnell LH,Menck HR.The national cancer data base report on cutaneous and noncutaneous melanoma:a summary of 84,836 cases from the past decade[J].Cancer,1998,83(8):1664-1678.DOI:10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G [2] McLaughlin CC,Wu XC,Jemal A,et al. Incidence of noncutaneous melanomas in the U.S.[J].Cancer,2005,103(5):1000-1007.DOI:10.1002/cncr.20866 [3] Lazarev S,Gupta V,Hu K,et al. Mucosal melanoma of the head and neck:a systematic review of the literature[J].Int J Radiat Oncol Biol Phys,2014,90(5):1108-1118.DOI:10.1016/j.ijrobp.2014.03.042 [4] Takagi M,Ishikawa G,Mori W.Primary malignant melanoma of the oral cavity in Japan. With special reference to mucosal melanosis[J].Cancer,1974,34(2):358-370 [5] Cheng YF,Lai CC,Ho CY,et al. Toward a better understanding of sinonasal mucosal melanoma:clinical review of 23 cases[J].J Chin Med Assoc,2007,70(1):24-29.DOI:10.1016/S1726-4901(09)70296-5 [6] Jethanamest D,Vila PM,Sikora AG,et al. Predictors of survival in mucosal melanoma of the head and neck[J].Ann Surg Oncol,2011,18(10):2748-2756.DOI:10.1245/s10434-011-1685-4 [7] Patel SG,Prasad ML,Escrig M,et al. Primary mucosal malignant melanoma of the head and neck[J].Head Neck,2002,24(3):247-257 [8] Lombardi D,Bottazzoli M,Turri-Zanoni M,et al. Sinonasal mucosal melanoma:a 12-year experience of 58 cases[J].Head Neck,2016,38 Suppl 1:E1737-1745.DOI:10.1002/hed.24309 [9] Sun CZ,Chen YF,Jiang YE,et al. Treatment and prognosis of oral mucosal melanoma[J].Oral Oncol,2012,48(7):647-652.DOI:10.1016/j.oraloncology.2012.01.019. [10] Lourenco SV,A MS,Sotto MN,et al. Primary oral mucosal melanoma:a series of 35 new cases from South America[J].Am J Dermatopathol,2009,31(4):323-330.DOI:10.1097/DAD.0b013e3181a0 d37c. [11] Prasad ML,Patel SG,Huvos AG,et al. Primary mucosal melanoma of the head and neck:a proposal for microstaging localized,Stage Ⅰ(lymph node-negative) tumors[J].Cancer,2004,100(8):1657-1664.DOI:10.1002/cncr.20201. [12] Ballantyne AJ.Malignant melanoma of the skin of the head and neck:an analysis of 405 cases[J].Am J Surg,1970,120(4):425-431.DOI:10.1016/S0002-9610(70)80001-0. [13] Edge SB,Compton CC.The American joint committee on cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM[J].Ann Surg Oncol,2010,17(6):1471-1474.DOI:10.1245/s10434-010-0985-4. [14] Gal TJ,Silver N,Huang B.Demographics and treatment trends in sinonasal mucosal melanoma[J].Laryngoscope,2011,121(9):2026-2033.DOI:10.1002/lary.21925. [15] Penel N,Mallet Y,Mirabel X,et al. Primary mucosal melanoma of head and neck:prognostic value of clear margins[J].Laryngoscope,2006,116(6):993-995.DOI:10.1097/01.mlg.0000217236.06585.a9. [16] Medina JE,Ferlito A,Pellitteri PK,et al. Current management of mucosal melanoma of the head and neck[J].J Surg Oncol,2003,83(2):116-122.DOI:10.1002/jso.10247. [17] Manolidis S,Donald PJ.Malignant mucosal melanoma of the head and neck:review of the literature and report of 14 patients[J].Cancer,1997,80(8):1373-1386. [18] Krengli M,Masini L,Kaanders JH,et al. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract:analysis of 74 cases. A rare cancer network study[J].Int J Radiat Oncol Biol Phys,2006,65(3):751-759.DOI:10.1016/j.ijrobp.2006.01.016. [19] Starek I,Koranda P,Benes P.Sentinel lymph node biopsy:a new perspective in head and neck mucosal melanoma?[J].Melanoma Res,2006,16(5):423-427.DOI:10.1097/01.cmr.0000222603.57932.b6. [20] Temam S,Mamelle G,Marandas P,et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck[J].Cancer,2005,103(2):313-319.DOI:10.1002/cncr.20775. [21] Owens JM,Roberts DB,Myers JN.The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region[J].Arch Otolaryngol Head Neck Surg,2003,129(8):864-868.DOI:10.1001/archotol.129.8.864. [22] Benlyazid A,Thariat J,Temam S,et al. Postoperative radiotherapy in head and neck mucosal melanoma:a GETTEC study[J].Arch Otolaryngol Head Neck Surg,2010,136(12):1219-1225.DOI:10.1001/archoto.2010.217. [23] Nakashima JP,Viégas CM,Fassizoli AL,et al. Postoperative adjuvant radiation therapy in the treatment of primary head and neck mucosal melanomas[J].ORL J Otorhinolaryngol Relat Spec,2008,70(6):344-351.DOI:10.1159/000163029. [24] Moreno MA,Roberts DB,Kupferman ME,et al. Mucosal melanoma of the nose and paranasal sinuses,a contemporary experience from the M.D.Anderson Cancer Center[J].Cancer,2010,116(9):2215-2223.DOI:10.1002/cncr.24976. [25] Vandenhende C,Leroy X,Chevalier D,et al. Sinonasal mucosal melanoma:retrospective survival study of 25 patients[J].J Laryngol Otol,2012,126(2):147-151.DOI:10.1017/S0022215111002519. [26] Saigal K,Weed DT,Reis IM,et al. Mucosal melanomas of the head and neck:the role of postoperative radiation therapy[J].ISRN Oncol,2012,2012:785131.DOI:10.5402/2012/785131. [27] Meleti M,Leemans CR,de Bree R,et al. Head and neck mucosal melanoma:experience with 42 patients,with emphasis on the role of postoperative radiotherapy[J].Head Neck,2008,30(12):1543-1551.DOI:10.1002/hed.20901. [28] Wushou A,Hou J,Zhao YJ,et al. Postoperative adjuvant radiotherapy improves loco-regional recurrence of head and neck mucosal melanoma[J].J Craniomaxillofac Surg,2015,43(4):553-558.DOI:10.1016/j.jcms.2015.02.011. [29] Christopherson K,Malyapa RS,Werning JW,et al. Radiation therapy for mucosal melanoma of the head and neck[J].Am J Clin Oncol,2015,38(1):87-89.DOI:10.1097/COC.0b013e31828 d73bf. [30] Lee SP,Shimizu KT,Tran LM,et al. Mucosal melanoma of the head and neck:the impact of local control on survival[J].Laryngoscope,1994,104(2):121-126.DOI:10.1288/00005537-199402000-00001. [31] Gilligan D,Slevin NJ.Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses[J].Br J Radiol,1991,64(768):1147-1150.DOI:10.1259/0007-1285-64-768-1147. [32] Liao JJ,Parvathaneni U,Laramore GE,et al. Fast neutron radiotherapy for primary mucosal melanomas of the head and neck[J].Head Neck,2014,36(8):1162-1167.DOI:10.1002/hed.23428. [33] Fuji H,Yoshikawa S,Kasami M,et al. High-dose proton beam therapy for sinonasal mucosal malignant melanoma[J].Radiat Oncol,2014,9:162.DOI:10.1186/1748-717X-9-162. [34] Yanagi T,Mizoe JE,Hasegawa A,et al. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy[J].Int J Radiat Oncol Biol Phys,2009,74(1):15-20.DOI:10.1016/j.ijrobp.2008.07.056. [35] Overgaard J.The role of radiotherapy in recurrent and metastatic malignant melanoma:a clinical radiobiological study[J].Int J Radiat Oncol Biol Phys,1986,12(6):867-872.DOI:10.1016/0360-3016(86)90378-0. [36] Wada H,Nemoto K,Ogawa Y,et al. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan[J].Int J Radiat Oncol Biol Phys,2004,59(2):495-500.DOI:10.1016/j.ijrobp.2003.11.013. [37] Sause WT,Cooper JS,Rush S,et al. Fraction size in external beam radiation therapy in the treatment of melanoma[J].Int J Radiat Oncol Biol Phys,1991,20(3):429-432.DOI:10.1016/0360-3016(91)90053-7. [38] Trotti A,Peters LJ.Role of radiotherapy in the primary management of mucosal melanoma of the head and neck[J].Semin Surg Oncol,1993,9(3):246-250. [39] Ahn HJ,Na Ⅱ,Park YH,et al. Role of adjuvant chemotherapy in malignant mucosal melanoma of the head and neck[J].Oral Oncol,2010,46(8):607-611.DOI:10.1016/j.oraloncology.2010.05.005. [40] Yang X,Ren GX,Zhang CP,et al. Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma[J].BMC Cancer,2010,10:623.DOI:10.1186/1471-2407-10-623. [41] Ives NJ,Stowe RL,Lorigan P,et al. Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma:a meta-analysis of 18 trials involving 2,621 patients[J].J Clin Oncol,2007,25(34):5426-5434.DOI:10.1200/JCO.2007.12.0253. [42] Sun CZ,Chen FJ,Song M,et al. Clinical analysis of 51 cases of oral mucosal melanoma[J].Chin J Stomatol,2011,46(9):528-530.DOI:10.3760/cma.j.issn.1002-0098.2011.09.005. [43] Guo J,Si L,Kong Y,et al. Phase Ⅱ,open-label,single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification[J].J Clin Oncol,2011,29(21):2904-2909.DOI:10.1200/JCO.2010.33.9275. [44] Hodi FS,O′Day SJ,McDermott DF,et al. Improved survival with ipilimumab in patients with metastatic melanoma[J].N Engl J Med,2010,363(8):711-723.DOI:10.1056/NEJMoa1003466. [45] Min L,Hodi FS.Anti-PD1 following ipilimumab for mucosal melanoma:durable tumor response associated with severe hypothyroidism and rhabdomyolysis[J].Cancer Immunol Res,2014,2(1):15-18.DOI:10.1158/2326-6066.CIR-13-0146.
2017, Vol. 26 
